Immunohistochemical analysis of Sox9 expression in periosteum of tibia and calvaria after surgical release of the periosteum

Takashi Fujii, Takaaki Ueno, Toshimasa Kagawa, Toshio Sugahara, Toshio Yamamoto

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Sox9 is a transcription factor belonging to the SRY family of high-mobility box proteins, and plays a major role in endochondral ossification. Sox9 is a potent activator of the type-2 collagen pheno-type marker of articular cartilage. Regulation of osteogenic molecular signals in periosteal bone formation has not yet been elucidated yet. The purpose of the present study was to analyze histologically the bone formation in surgically released and repositioned periosteum, and to determine expression of Sox9 and type-2 collagen in periosteal bone formation of tibia and calvaria. After surgery, the released tibial periosteum formed ectopic cartilage. At 7 days, a combination of endochondral and intramembranous ossification was apparent. Some fibroblasts derived from the released periosteum showed Sox9 expression. Chondrocytes and cartilage matrix both displayed type-2 collagen expression. At 7 days, an additional new bone was formed on the calvaria. Osteoblasts and fibroblasts derived from released calvarial periosteum did not express Sox9 or type-2 collagen. Sox9 was not expressed throughout the process periosteal bone formation on the calvaria. It is concluded that we revealed Sox9 and type-2 collagen expression in periosteal cells after periosteum release and that the generative potential of periosteal cells of calvaria is different from that of tibia.

Original languageEnglish
Pages (from-to)427-437
Number of pages11
JournalActa Histochemica
Volume106
Issue number6
DOIs
Publication statusPublished - Feb 24 2005

Fingerprint

Periosteum
Tibia
Collagen Type II
Osteogenesis
Skull
Cartilage
Fibroblasts
Articular Cartilage
Chondrocytes
Osteoblasts
Transcription Factors
Bone and Bones
Proteins

Keywords

  • Immunohistochemistry
  • Periosteum
  • Sox9
  • Type-2 collagen

ASJC Scopus subject areas

  • Cell Biology

Cite this

Immunohistochemical analysis of Sox9 expression in periosteum of tibia and calvaria after surgical release of the periosteum. / Fujii, Takashi; Ueno, Takaaki; Kagawa, Toshimasa; Sugahara, Toshio; Yamamoto, Toshio.

In: Acta Histochemica, Vol. 106, No. 6, 24.02.2005, p. 427-437.

Research output: Contribution to journalArticle

Fujii, Takashi ; Ueno, Takaaki ; Kagawa, Toshimasa ; Sugahara, Toshio ; Yamamoto, Toshio. / Immunohistochemical analysis of Sox9 expression in periosteum of tibia and calvaria after surgical release of the periosteum. In: Acta Histochemica. 2005 ; Vol. 106, No. 6. pp. 427-437.
@article{3568fdef40814826a5c876b4d90b2afa,
title = "Immunohistochemical analysis of Sox9 expression in periosteum of tibia and calvaria after surgical release of the periosteum",
abstract = "Sox9 is a transcription factor belonging to the SRY family of high-mobility box proteins, and plays a major role in endochondral ossification. Sox9 is a potent activator of the type-2 collagen pheno-type marker of articular cartilage. Regulation of osteogenic molecular signals in periosteal bone formation has not yet been elucidated yet. The purpose of the present study was to analyze histologically the bone formation in surgically released and repositioned periosteum, and to determine expression of Sox9 and type-2 collagen in periosteal bone formation of tibia and calvaria. After surgery, the released tibial periosteum formed ectopic cartilage. At 7 days, a combination of endochondral and intramembranous ossification was apparent. Some fibroblasts derived from the released periosteum showed Sox9 expression. Chondrocytes and cartilage matrix both displayed type-2 collagen expression. At 7 days, an additional new bone was formed on the calvaria. Osteoblasts and fibroblasts derived from released calvarial periosteum did not express Sox9 or type-2 collagen. Sox9 was not expressed throughout the process periosteal bone formation on the calvaria. It is concluded that we revealed Sox9 and type-2 collagen expression in periosteal cells after periosteum release and that the generative potential of periosteal cells of calvaria is different from that of tibia.",
keywords = "Immunohistochemistry, Periosteum, Sox9, Type-2 collagen",
author = "Takashi Fujii and Takaaki Ueno and Toshimasa Kagawa and Toshio Sugahara and Toshio Yamamoto",
year = "2005",
month = "2",
day = "24",
doi = "10.1016/j.acthis.2004.10.002",
language = "English",
volume = "106",
pages = "427--437",
journal = "Acta Histochemica",
issn = "0065-1281",
publisher = "Urban und Fischer Verlag Jena",
number = "6",

}

TY - JOUR

T1 - Immunohistochemical analysis of Sox9 expression in periosteum of tibia and calvaria after surgical release of the periosteum

AU - Fujii, Takashi

AU - Ueno, Takaaki

AU - Kagawa, Toshimasa

AU - Sugahara, Toshio

AU - Yamamoto, Toshio

PY - 2005/2/24

Y1 - 2005/2/24

N2 - Sox9 is a transcription factor belonging to the SRY family of high-mobility box proteins, and plays a major role in endochondral ossification. Sox9 is a potent activator of the type-2 collagen pheno-type marker of articular cartilage. Regulation of osteogenic molecular signals in periosteal bone formation has not yet been elucidated yet. The purpose of the present study was to analyze histologically the bone formation in surgically released and repositioned periosteum, and to determine expression of Sox9 and type-2 collagen in periosteal bone formation of tibia and calvaria. After surgery, the released tibial periosteum formed ectopic cartilage. At 7 days, a combination of endochondral and intramembranous ossification was apparent. Some fibroblasts derived from the released periosteum showed Sox9 expression. Chondrocytes and cartilage matrix both displayed type-2 collagen expression. At 7 days, an additional new bone was formed on the calvaria. Osteoblasts and fibroblasts derived from released calvarial periosteum did not express Sox9 or type-2 collagen. Sox9 was not expressed throughout the process periosteal bone formation on the calvaria. It is concluded that we revealed Sox9 and type-2 collagen expression in periosteal cells after periosteum release and that the generative potential of periosteal cells of calvaria is different from that of tibia.

AB - Sox9 is a transcription factor belonging to the SRY family of high-mobility box proteins, and plays a major role in endochondral ossification. Sox9 is a potent activator of the type-2 collagen pheno-type marker of articular cartilage. Regulation of osteogenic molecular signals in periosteal bone formation has not yet been elucidated yet. The purpose of the present study was to analyze histologically the bone formation in surgically released and repositioned periosteum, and to determine expression of Sox9 and type-2 collagen in periosteal bone formation of tibia and calvaria. After surgery, the released tibial periosteum formed ectopic cartilage. At 7 days, a combination of endochondral and intramembranous ossification was apparent. Some fibroblasts derived from the released periosteum showed Sox9 expression. Chondrocytes and cartilage matrix both displayed type-2 collagen expression. At 7 days, an additional new bone was formed on the calvaria. Osteoblasts and fibroblasts derived from released calvarial periosteum did not express Sox9 or type-2 collagen. Sox9 was not expressed throughout the process periosteal bone formation on the calvaria. It is concluded that we revealed Sox9 and type-2 collagen expression in periosteal cells after periosteum release and that the generative potential of periosteal cells of calvaria is different from that of tibia.

KW - Immunohistochemistry

KW - Periosteum

KW - Sox9

KW - Type-2 collagen

UR - http://www.scopus.com/inward/record.url?scp=13644256028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13644256028&partnerID=8YFLogxK

U2 - 10.1016/j.acthis.2004.10.002

DO - 10.1016/j.acthis.2004.10.002

M3 - Article

VL - 106

SP - 427

EP - 437

JO - Acta Histochemica

JF - Acta Histochemica

SN - 0065-1281

IS - 6

ER -